Cambridge Healthtech Institute’s 3rd Annual

Sensors, Wearables and Digital Biomarkers in Clinical Trials

Technology, Infrastructure and Analytics for Digital Data Sources & Endpoints

February 19-20, 2020

Clinical research industry is moving toward end-to-end digital clinical trials. The data collection should stay in line with this inevitable change and wearables and point-of-care sensors address this need. Furthermore, digital biomarkers translate new data sources into clinically actionable insights. CHI’s 3rd Annual Sensors, Wearables and Digital Biomarkers in Clinical Trials conference is designed to feature case studies of clinical trials that already employ sensors and wearables, as well as to discuss the future steps needed for implementation of digital biomarkers and endpoints in clinical trials.

Stay on and attend Part 2 (Thurs-Fri): Clinical Technology and Innovation

Preliminary Agenda


Digital Biomarkers: Translating New Digital Data Sources into Clinical Insights to Enhance Drug Development

Luis Garcia-Gancedo, PhD, Fellow & Director, Digital Biomarkers, GlaxoSmithKline

Regulatory Considerations during Mobile Medical App Development

Michael Benecky, PhD, Senior Director, Global Regulatory Affairs, Precision and Digital Medicine, R&D Chief Regulatory Office, GlaxoSmithKline

An Exploration of Effective Regulator Engagement Regarding the Use of Digital Endpoints

Suraj Ramachandran, Director, Device and Digital Health, Regulatory Affairs, Merck


Ipredict: A Case Study in Applying Digital Sensors Technology and Machine Learning to Predict Asthma Control

Bhaskar Dutta, Principal Scientist, Advanced Analytics Center, AstraZeneca

PANEL DISCUSSION: Novel Digital Endpoints in Clinical Research: Technology, Infrastructure, Relationship with Technology Providers

Moderator: Michelle Crouthamel, Director, Digital Health & Innovation, AbbVie
Panelists: Krista M. Emmons, Associate Director, Portfolio Relationship Management, Portfolio Relationship & Sourcing Management (PRSM), Medical & Development, Astellas Pharma Global Development, Inc.
Speakers of the Day


Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes:
For more details on the Participant Engagement Award:


Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing:


Stay on and attend Part 2 (Thurs-Fri): Clinical Technology and Innovation

For more details on the conference, please contact:
Marina Fishtinsky, MD
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781.972.5496

For partnering and sponsorship information, please contact:

Companies A-K
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5457

Companies L-Z
Patty Rose
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.1349